Related Experiment Video
Updated: May 28, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
[Hemorrhagic complications of acute coronary syndromes treatment]
Mauro Echavarría-Pinto1, Úrsulo Juárez-Herrera, Luis Antonio Meillón-García
1Departamento de Médicos Residentes.
Insights
Treating acute coronary syndromes involves balancing reperfusion benefits against bleeding risks. Identifying high-risk patients and managing bleeding events are crucial for improving patient outcomes.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Context:
- Acute coronary syndromes (ACS) pose a significant public health challenge.
- Effective ACS treatment aims for early reperfusion and prevention of recurrent ischemic events.
- Current therapies, including thrombolytics, anticoagulants, and antiplatelets, improve ischemic prognosis but increase bleeding risk.
Purpose:
- To highlight the dual nature of ACS treatments, balancing ischemic benefits against bleeding complications.
- To emphasize the negative impact of bleeding on patient outcomes and treatment efficacy.
- To stress the importance of identifying high bleeding risk patients and optimizing therapeutic strategies.
Summary:
- ACS treatments improve outcomes but carry a significant bleeding risk.
- Bleeding complications negatively impact patient evolution and can be detrimental.
- Recognizing high bleeding risk and managing bleeding events are essential for optimal patient prognosis.
Impact:
- Improved patient selection for ACS therapies based on bleeding risk.
- Enhanced management protocols for bleeding complications in ACS patients.
- Reduced morbidity and mortality associated with ACS through optimized risk-benefit assessment.
Abstract:
Acute coronary syndromes represent a problem of public health. The main goal of the treatment includes early reperfusion and avoidance of recurrent ischemic events. For this, thrombolytic, anticoagulant and antiplatelet drugs are used and, although they clearly improve the ischemic prognosis, are also associated with bleeding. It is now clear that bleeding has a negative impact in the patient's evolution and that its treatment can be also detrimental. It is important to recognize patients at high bleeding risk and to choose the therapy with the best risk-benefit profile. If the patient develops bleeding, it should be identified and treated properly to minimize its negative impact in the patient´s prognosis.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Hemorrhagic Stroke l: Introduction
Acute Coronary Syndrome V: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Coronary Syndrome III: Diagnostic Studies
